GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Selling, General, & Admin. Expense

Changchun BCHT Biotechnology Co (SHSE:688276) Selling, General, & Admin. Expense : ¥740 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Changchun BCHT Biotechnology Co's selling, general, & admin. expense for the three months ended in Mar. 2024 was ¥135 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥740 Mil.


Changchun BCHT Biotechnology Co Selling, General, & Admin. Expense Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Selling, General, & Admin. Expense Chart

Changchun BCHT Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling, General, & Admin. Expense
Get a 7-Day Free Trial 469.51 594.71 481.33 471.29 707.96

Changchun BCHT Biotechnology Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.16 131.48 323.67 149.65 135.19

Competitive Comparison of Changchun BCHT Biotechnology Co's Selling, General, & Admin. Expense

For the Drug Manufacturers - Specialty & Generic subindustry, Changchun BCHT Biotechnology Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changchun BCHT Biotechnology Co's Selling, General, & Admin. Expense Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changchun BCHT Biotechnology Co's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Changchun BCHT Biotechnology Co's Selling, General, & Admin. Expense falls into.



Changchun BCHT Biotechnology Co Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥740 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changchun BCHT Biotechnology Co  (SHSE:688276) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Changchun BCHT Biotechnology Co Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Traded in Other Exchanges
N/A
Address
No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012
Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.
Executives
Shi Nian Min Core technical personnel
Jiang Chun Lai Directors, senior managers, core technical personn
Zhu Chang Lin Core technical personnel
Wei Wei Senior management, core technical personnel
Yu Bing senior management
Liu Da Wei Senior management, core technical personnel
Meng Zhao Feng senior management
Zhang Zhe senior management
Kong Wei Directors, senior managers, core technical personn
Feng Da Qiang Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines